Welcome to LookChem.com Sign In|Join Free

CAS

  • or

191399-17-4

Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

191399-17-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 191399-17-4 Structure

  • Basic information

    1. Product Name: Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI)
    2. Synonyms: Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI)
    3. CAS NO:191399-17-4
    4. Molecular Formula: C6H8N2O2
    5. Molecular Weight: 140.13992
    6. EINECS: N/A
    7. Product Categories: ACETYLGROUP
    8. Mol File: 191399-17-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI)(191399-17-4)
    11. EPA Substance Registry System: Ethanone, 1-(2-amino-4-methyl-5-oxazolyl)- (9CI)(191399-17-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 191399-17-4(Hazardous Substances Data)

191399-17-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 191399-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,3,9 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 191399-17:
(8*1)+(7*9)+(6*1)+(5*3)+(4*9)+(3*9)+(2*1)+(1*7)=164
164 % 10 = 4
So 191399-17-4 is a valid CAS Registry Number.

191399-17-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-amino-4-methyl-1,3-oxazol-5-yl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(2-Amino-4-methyl-oxazol-5-yl)-ethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:191399-17-4 SDS

191399-17-4Downstream Products

191399-17-4Relevant articles and documents

Friedel-Crafts Reactions of 2-Amino-4-(alkyl or aryl)oxazoles with Acid Chlorides and Acid Anhydrides: Synthesis of 5-Acyl-2-amino-4-alkyloxazoles

Mekonnen, Belew,Crank, George

, p. 567 - 572 (1997)

Acid chlorides and anhydrides react with 2-amino-4-alkyloxazoles in the presence of aluminum chloride to produce 5-acyl substituted 2-amino-4-alkyloxazoles in modest yields. However, in the absence of the Lewis acid reaction occurs at the amino group to give the corresponding amides. This provides a viable entry for functionalising and making carbon-carbon bond at C-5 of this heterocyclic system.

Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action

Ohta, Hiroshi,Ishizaka, Tomoko,Tatsuzuki, Makoto,Yoshinaga, Mitsukane,Iida, Izumi,Yamaguchi, Tomomi,Tomishima, Yasumitsu,Futaki, Nobuko,Toda, Yoshihisa,Saito, Shuji

, p. 1111 - 1124 (2008/09/17)

In this study, a novel series of CB2 receptor agonist imine derivatives, 1-6, was synthesized and evaluated for activity against the CB2 receptor. In a previous paper we reported the synthesis and SARs of thiazole derivative 1, a pot

THIAZOLE DERIVATIVES AND USE THEREOF

-

Page/Page column 77; 78, (2008/06/13)

The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 191399-17-4